Herpes News and Research RSS Feed - Herpes News and Research

Herpes is an infection caused by two different but closely related viruses — herpes simplex virus type 1 (HSV-1) or cold sores and herpes simplex virus type 2 (HSV-2) or genital herpes. Both are easy to catch. They have similar symptoms (blisters or sores) and both can occur on different parts of the body. When the infection is on the mouth, it is called oral herpes. When it is on or near the sex organs, it is called genital herpes. There is no cure for herpes. Treatments are available to speed up the healing of the genital sores.
Study finds viruses communicating with one another

Study finds viruses communicating with one another

Viruses may be stealthy invaders, but a study at the Weizmann Institute of Science reveals a new, chatty side of some: for the first time, viruses have been found communicating with one another. [More]
New genital herpes vaccine candidate shows promising results in preclinical tests

New genital herpes vaccine candidate shows promising results in preclinical tests

Approximately 500 million people around the world are infected with the genital herpes virus known as herpes simplex virus 2 (HSV2). [More]
Researchers find explanation for link between persistent infection and long-term immunity

Researchers find explanation for link between persistent infection and long-term immunity

Many infectious diseases are one and done; people get sick once and then they are protected from another bout of the same illness. [More]
Important vaccines that should not be missed by adults, elders and pregnant women

Important vaccines that should not be missed by adults, elders and pregnant women

Vaccines are an important part of routine healthcare for adults, seniors and women who are pregnant. [More]
Nanoparticle exposure can trigger dormant viruses in lung tissue cells

Nanoparticle exposure can trigger dormant viruses in lung tissue cells

Nanoparticles from combustion engines can activate viruses that are dormant in lung tissue cells. This is the result of a study by researchers of Helmholtz Zentrum München, a partner in the German Center for Lung Research, which has now been published in the journal 'Particle and Fibre Toxicology'. [More]
Could pathogen infection really lead to Alzheimer’s?

Could pathogen infection really lead to Alzheimer’s?

New concepts of infectious disease are evolving with the realization that pathogens are key players in the development of progressive chronic diseases that originally were not thought to be infectious. Infection is well-known to be associated with numerous neurological diseases for which... [More]
New research suggests novel combination approach to fight against gliomas

New research suggests novel combination approach to fight against gliomas

"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months. [More]
Slayback Pharma launches Generic Zovirax Ointment 5% for herpes virus infections

Slayback Pharma launches Generic Zovirax Ointment 5% for herpes virus infections

Slayback Pharma LLC is pleased to announce the launch of Generic Zovirax Ointment (Acyclovir Ointment) 5%, by its out-licensee - Sandoz (Fougera). Slayback had developed the product and out-licensed the sales and marketing rights to Sandoz. [More]
USPSTF recommends against routine serologic screening for genital HSV infection

USPSTF recommends against routine serologic screening for genital HSV infection

The U.S. Preventive Services Task Force recommends against routine serologic screening (via a blood test) for genital herpes simplex virus infection in asymptomatic adolescents and adults, including those who are pregnant. [More]
Study compares medications for treatment of persons with recurrent genital herpes

Study compares medications for treatment of persons with recurrent genital herpes

In a study appearing in the December 20 issue of JAMA, Anna Wald, M.D., M.P.H., of the University of Washington & Fred Hutchinson Cancer Research Center, Seattle, and colleagues compared the medications pritelivir and valacyclovir for reducing genital herpes simplex virus shedding and lesions in persons with recurrent genital herpes. [More]
Newborns with CMV may have increased risk of developing acute lymphocytic leukemia

Newborns with CMV may have increased risk of developing acute lymphocytic leukemia

Newborns with congenital cytomegalovirus (CMV) -- a common virus in the herpes family -- may have an increased risk of developing acute lymphocytic leukemia (ALL), according to new research published online today in Blood, the Journal of the American Society of Hematology. The study suggests the risk is even greater in Hispanic children. [More]
Scientists isolate and characterize therapy-resistant dormant leukemia cells

Scientists isolate and characterize therapy-resistant dormant leukemia cells

Dr. Irmela Jeremias from Helmholtz Zentrum München and her colleagues have succeeded in finding a small population of inactive leukemia cells that is responsible for relapse of the disease. [More]
Psychology researcher explores barriers deterring MSM from seeking information on STIs

Psychology researcher explores barriers deterring MSM from seeking information on STIs

A researcher at Birmingham City University is undertaking research into the social and cognitive barriers hindering men who have sex with other men (MSM) from finding out more information about sexually transmitted infections (STIs). [More]
Scientists discover incident commander in the brain that defends against invading virus

Scientists discover incident commander in the brain that defends against invading virus

Imagine seeing a building on fire. You grab the phone and call the fire service. What happens next can be compared to the discovery made by researchers from Aarhus University. [More]
Pubic hair grooming linked to increased STI risk, says study

Pubic hair grooming linked to increased STI risk, says study

Removing or trimming pubic hair is associated with an increased risk of contracting a sexually transmitted disease, according to a study published in Sexually Transmitted Infections. [More]
Okayama University researchers find way to prevent replication of influenza viral RNA

Okayama University researchers find way to prevent replication of influenza viral RNA

Researchers at Okayama University have successfully cleaved influenza viral RNA to prevent its replication using novel artificial RNA restriction enzymes in laboratory cell cultures. [More]
NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

NYU Langone Medical Center will lead a five-year, 60-center clinical trial to evaluate new treatment protocols for herpes zoster ophthalmicus (HZO), a form of shingles that can seriously and permanently affect the eye. [More]
Suppressed vaginal immune response makes women more susceptible to RNA viruses

Suppressed vaginal immune response makes women more susceptible to RNA viruses

Scientists at the Gladstone Institutes discovered that the vaginal immune system is suppressed in response to RNA viruses, such as Zika. [More]
NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

The National Center for Advancing Translational Sciences recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc. to initiate a partnership with Texas Biomedical Research Institute aimed at repurposing an antimalarial for use against the Ebola virus. [More]
DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform. [More]
Advertisement
Advertisement